BOSTON (Reuters) - Insys Therapeutics Inc said on Thursday it was taking a $4.5 million charge in connection with resolving a lawsuit by Illinois' attorney general claiming it deceptively marketed a fentanyl-based cancer pain drug for off-label uses.
from Reuters: U.S. http://ift.tt/2v2CV4U
No comments:
Post a Comment